摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,2R,3S,4S)-4-(tert-butoxymethyl)-2,3-(isopropylidenedioxy)cyclopentan-1-ol | 192118-38-0

中文名称
——
中文别名
——
英文名称
(1R,2R,3S,4S)-4-(tert-butoxymethyl)-2,3-(isopropylidenedioxy)cyclopentan-1-ol
英文别名
(3aR,4R,6S,6aS)-2,2-dimethyl-6-[(2-methylpropan-2-yl)oxymethyl]-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol
(1R,2R,3S,4S)-4-(tert-butoxymethyl)-2,3-(isopropylidenedioxy)cyclopentan-1-ol化学式
CAS
192118-38-0
化学式
C13H24O4
mdl
——
分子量
244.331
InChiKey
KWLNDANQZQEFIH-ZRUFSTJUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    47.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Asymmetric Synthesis and Antiviral Activities of <scp>l</scp>-Carbocyclic 2‘,3‘-Didehydro-2‘,3‘-dideoxy and 2‘,3‘-Dideoxy Nucleosides
    作者:Peiyuan Wang、Beth Gullen、M. Gary Newton、Yung-Chi Cheng、Reymond F. Schinazi、Chung K. Chu
    DOI:10.1021/jm9901327
    日期:1999.8.1
    syntheses of L-carbocyclic 2',3'-didehydro-2',3'-dideoxy- and 2',3'-dideoxypyrimidine and purine nucleoside analogues were accomplished, and their anti-HIV and anti-HBV activities were evaluated. The key intermediate, (1S, 4R)-1-benzoyloxy-4-(tert-butoxymethyl)cyclopent-2-ene (7), was prepared by benzoylation of the alcohol 2, selective deprotection of the isopropylidene group of 3, followed by thermal elimination
    完成了L-环2',3'-didehydro-2',3'-二-和2',3'-二嘧啶嘌呤核苷类似物的不对称合成,并评估了它们的抗HIV和抗HBV活性。关键中间体(1S,4R)-1-基-4-(叔丁甲基)环戊-2-(7)是通过对醇2进行甲酰化而制备的,对3的异亚丙基进行选择性保护,然后通过环状原酸进行热消除或通过环状碳酸进行。还通过从保护的核苷经由环原酸进行热消除而合成了目标化合物。发现L-环2',3'-didehydro-2',3'-二腺苷(34)表现出有效的抗HBV活性(EC(50)= 0.9 microM)和中等的抗HIV活性(EC(50 )= 2。
  • Asymmetric synthesis and anti-HIV activity of L-carbocyclic 2′,3′-didehydro-2′,3′-dideoxyadenosine
    作者:Peiyuan Wang、Raymond F. Schinazi、Chung K. Chu
    DOI:10.1016/s0960-894x(98)00278-9
    日期:1998.7
    Asymmetric synthesis of L-carbocyclic 2',3'-didehydro-2',3'-dideoxyadenosine and its analogs were accomplished and their anti-HIV activities were evaluated. It was found that L-carbocyclic 2',3'-didehydro-2',3'-dideoxyadenosine exhibited moderately potent anti-HIV (EC50 = 2.4 microM) activity in human PBM cells without cytotoxicity up to 100 microM.
    完成了L-环2',3'-didehydro-2',3'-二腺苷及其类似物的不对称合成,并评估了它们的抗HIV活性。发现L-环2',3'-didehydro-2',3'-二腺苷在人PBM细胞中表现出中等有效的抗-HIV(EC50 = 2.4 microM)活性,而对细胞的毒性最高至100 microM。
  • Solid Phase Synthesis of Carbocyclic <scp>l</scp>-2‘-Deoxynucleosides
    作者:Hyunah Choo、Youhoon Chong、Chung K. Chu
    DOI:10.1021/ol015783n
    日期:2001.5.1
    [GRAPHICS]Carbocyclic L-2 ' deoxynucleosides 17 were synthesized on solid phase in four steps from the appropriately protected intermedate 11, The Mitsunobu reaction was used as a condensation method between the carbocyclic moiety and heterocyclic bases. The regioselectivity of the carbocyclic nucleosides was compared between the solid and solution phase syntheses.
  • Asymmetric synthesis of L-cyclopentyl carbocyclic nucleosides
    作者:Peiyuan Wang、Luigi A. Agrofoglio、M. Gary Newton、Chung K. Chu
    DOI:10.1016/s0040-4039(97)00898-8
    日期:1997.6
    Asymmetric synthesis of L-carbocyclic nucleosides, (+)-beta-L-aristeromycin (11) and its thymine analog (12) was accomplished. The key intermediate 3 was synthesized by a regioselective conjugate addition to the enone 1 followed by DIBAL-H reduction. Coupling of 4 with heterocycle or construction of heterocyle by a linear approach gave 11 and 12. This is the first asymmetric synthesis of L-cyclopentyl carbocyclic nucleosides. (C) 1997 Elsevier Science Ltd.
查看更多